Lv31
350 积分 2025-04-02 加入
Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis
1个月前
已完结
Combinations of HDAC Inhibitor and PPAR Agonist Induce Ferroptosis of Leukemic Stem Cell–like Cells in Acute Myeloid Leukemia
1个月前
已完结
DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma
2个月前
已完结
Differential RNA splicing as a potentially important driver mechanism in multiple myeloma
3个月前
已完结
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
3个月前
已完结
Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study
3个月前
已完结
Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)
3个月前
已完结
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial
3个月前
已完结
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
3个月前
已完结
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
3个月前
已完结